.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
US Department of Justice
Cantor Fitzgerald
Citi
Chubb
McKesson
AstraZeneca
Argus Health
Deloitte
Covington

Generated: July 21, 2017

DrugPatentWatch Database Preview

Pirfenidone - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for pirfenidone and what is the scope of pirfenidone patent protection?

Pirfenidone
is the generic ingredient in one branded drug marketed by Genentech Inc and is included in two NDAs. There are twenty patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Pirfenidone has one hundred and ninety-six patent family members in forty countries.

There are nine drug master file entries for pirfenidone. Two suppliers are listed for this compound.

Summary for Generic Name: pirfenidone

Tradenames:1
Patents:20
Applicants:1
NDAs:2
Drug Master File Entries: see list9
Suppliers / Packagers: see list2
Bulk Api Vendors: see list90
Clinical Trials: see list54
Patent Applications: see list3,011
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:pirfenidone at DailyMed

Pharmacology for Ingredient: pirfenidone

Ingredient-typePyridones
Drug ClassPyridone
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Genentech Inc
ESBRIET
pirfenidone
CAPSULE;ORAL022535-001Oct 15, 2014RXYesYes8,753,679► SubscribeY ► Subscribe
Genentech Inc
ESBRIET
pirfenidone
CAPSULE;ORAL022535-001Oct 15, 2014RXYesYes7,816,383► Subscribe ► Subscribe
Genentech Inc
ESBRIET
pirfenidone
CAPSULE;ORAL022535-001Oct 15, 2014RXYesYes7,635,707► Subscribe ► Subscribe
Genentech Inc
ESBRIET
pirfenidone
CAPSULE;ORAL022535-001Oct 15, 2014RXYesYes8,318,780► Subscribe ► Subscribe
Genentech Inc
ESBRIET
pirfenidone
CAPSULE;ORAL022535-001Oct 15, 2014RXYesYes7,767,225► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: pirfenidone

Country Document Number Estimated Expiration
Spain2387421► Subscribe
Georgia, Republic ofP20166455► Subscribe
European Patent Office3053580► Subscribe
African Regional IP Organization (ARIPO)200804390► Subscribe
Spain2496144► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Merck
UBS
Federal Trade Commission
Fish and Richardson
Chubb
QuintilesIMS
Healthtrust
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot